SB 934 California Senate · 2021-2022 Regular Session

California Childhood Cancer Research Fund Act.

Summary
Under existing law, the State Department of Health Care Services is responsible for the administration and oversight of various health care programs, including those related to cancer screening and research. This bill, the California Childhood Cancer Research Fund Act, would request the Regents of the University of California to establish and administer the Childhood Cancer Research Grant Program to provide funding to various entities to support research and treatment for children impacted by cancer and the long-term effects of cancer treatment. The bill would create the Childhood Cancer Research Council composed of 7 members, including specialists in pediatric oncology, appointed by the Governor, Senate Committee on Rules, or Speaker of the Assembly, and would require the council to develop the strategic objectives and priorities of the program and make grant recommendations to the University of California in accordance with the program's goals. The bill would require the council to submit an annual report to the Legislature describing the grants made, grants in progress, program accomplishments, and future program directions. The bill would create the Andrew Hirschman Childhood Cancer Research Fund for the implementation and administration of the grant program, upon appropriation by the Legislature. The bill would make these provisions operative until January 1, 2028.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2022
Committee Review
Aug 2022
Senate Passage
May 2022
Assembly Passage
Governor
Introduced Feb 7, 2022 Last action Aug 11, 2022
Floor votes · Senate May 26, 2022

How they voted

350
Passed · 2 other
Total votes 37
May 26, 2022
D Democratic29
28 Yea 1
96% Yea
R Republican8
7 Yea 1
87% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
27
Key actions
10
Committee
6
Amendments
5
Aug 11, 2022
Lower · Passed
August 11 hearing: Held in committee and under submission.
lower
Jul 29, 2022
Lower · Passed
August 3 hearing postponed by committee.
lower
Jun 22, 2022
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 15. Noes 0.) (June 21). Re-referred to Com. on APPR.
lower
Jun 9, 2022
Committee
Referred to Com. on HEALTH.
lower
May 26, 2022
Upper · Passed
Read third time. Passed. (Ayes 38. Noes 0. Page 3984.) Ordered to the Assembly.
upper
May 19, 2022
Upper · Passed
Read second time and amended. Ordered to second reading.
upper
May 19, 2022
Upper · Passed
From committee: Do pass as amended. (Ayes 7. Noes 0. Page 3775.) (May 19).
upper
Apr 26, 2022
Upper · Passed
From committee: Do pass and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 13. Noes 0. Page 3510.) (April 26). Re-referred to Com. on APPR.
upper
Apr 19, 2022
Upper · Passed
From committee with author's amendments. Read second time and amended. Re-referred to Com. on G.O.
upper
Apr 4, 2022
Upper · Passed
Read second time and amended. Re-referred to Com. on G.O.
upper
Mar 31, 2022
Upper · Passed
From committee: Do pass as amended and re-refer to Com. on G.O. with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 3273.) (March 30).
upper
Feb 16, 2022
Committee
Referred to Coms. on HEALTH and G.O.
upper
Feb 7, 2022
Introduced
Introduced. Read first time. To Com. on RLS. for assignment. To print.
upper
0 primary · 17 co-sponsors

Sponsors

No sponsor information available.